GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Molecular Insight Pharmaceuticals, Inc. (MIPIQ) [hlAlert]

Molecular Insight Pharmaceuticals, Inc. (Molecular Insight) is a biopharmaceutical company focused on the research, development and commercialization of molecular imaging pharmaceuticals and targeted radiotherapeutics designed to improve patient diagnosis, treatment and management. The Company is based in
Cambridge, Massachusetts. The Company?s molecular imaging radiopharmaceutical product candidate Zemiva is for the diagnosis of cardiac ischemia (insufficient blood flow to the heart muscle) and its other imaging candidate, Trofex is in development for the detection of metastatic prostate cancer. Its radiotherapeutic product candidates, Azedra and Onalta, are both radiolabeled small molecules being developed for the treatment of neuroendocrine cancers. Solazed is a small molecule radiotherapeutic that is being developed for the treatment of metastatic melanoma.
.
( Total: 5 Current Stock Recommendations )
Molecular Insight Pharmaceuticals, Inc.   (5)
Hold 20% Buy 80%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
3/10/2008  
Buy
  
10/11/2007  
Buy
  
11/14/2008  
Buy
  
12/11/2009  
Hold
  
10/15/2009  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy